Medicinal Cannabis—Potential Drug Interactions

Original article found hereMuhammad A. Alsherbiny 1,2,*  and Chun Guang Li 1,* 1 NICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia2 Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, EgyptAbstract The endocannabinoids system (ECS) has garnered considerable interest as a potential therapeutic target in var...
Read More

Press release: Patients express concern around the definition of palliative expressed in the SOPs

MCANZ has been inundated with concern over the artificially narrow definition of palliation in the SOPs put forward late Monday on the Medical Cannabis Bill. There are 2 key phrases that narrow the definition to exclude those who may be considered palliative in Generic terms. The bill defines palliation as such"a person requires palliation if, in the opinion of a medical practitioner or n...
Read More

Press release: DEA Deschedules CBD

Medical Cannabis Awareness New Zealand Press Release:   International Changes for Cannabis loom as the DEA Reschedules CBD  Today the US Drug enforcement agency (DEA) has made a historic announcement, announcing that Cannabidiol (CBD) is to be moved from the Schedule 1 to schedule 5.  This means it transitions from a drug rated worse the methamphetamine, to one at the safer end of presc...
Read More

Press Release: Shane Reti’s Private Members Bill a giant step forward for National on Medical Cannabis.

This afternoon the National Party has announced their own take on Medical Cannabis, with significant detail that has been left out of the Labour bill.“As a natural pessimist, I am surprised that any form of card system would fly with the National Caucus”“The inclusion of a card access system at pharmacies is a masterstroke, with patient choice preserved, and the input of medical profession...
Read More